financetom
Business
financetom
/
Business
/
GigaCloud Technology Insider Sold Shares Worth $3,517,520, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GigaCloud Technology Insider Sold Shares Worth $3,517,520, According to a Recent SEC Filing
Nov 26, 2025 12:49 AM

03:25 AM EST, 11/26/2025 (MT Newswires) -- Xinyan Hao, Chief Operating Officer, on November 21, 2025, sold 100,000 shares in GigaCloud Technology ( GCT ) for $3,517,520. Following the Form 4 filing with the SEC, Hao has control over a total of 407,486 Class A ordinary shares of the company, with 407,486 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1857816/000200414125000016/xslF345X05/wk-form4_1764115404.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's New Cheaper EV Models Still Have a Relatively High Price Point, Wedbush Says
Tesla's New Cheaper EV Models Still Have a Relatively High Price Point, Wedbush Says
Oct 8, 2025
10:49 AM EDT, 10/08/2025 (MT Newswires) -- Tesla's (TSLA) new, cheaper Model 3 and Y electric vehicles still have a high price point relative to other EVs in the market, Wedbush said in a Tuesday research note. We are relatively disappointed with this launch as the price point is only $5,000 lower than prior Model 3s and Ys, analysts wrote,...
TransCode Therapeutics to Acquire Polynoma, Receive Investment from CK Life Sciences
TransCode Therapeutics to Acquire Polynoma, Receive Investment from CK Life Sciences
Oct 8, 2025
10:54 AM EDT, 10/08/2025 (MT Newswires) -- TransCode Therapeutics ( RNAZ ) said Wednesday it has agreed to buy biotechnology immuno-oncology company Polynoma from a subsidiary of CK Life Sciences. The company also announced a $25 million equity investment from CK Life Sciences for the clinical development of TransCode's lead microRNA asset, TTX-MC138, into a phase 2 clinical study. Under...
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout
TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout
Oct 8, 2025
TransCode Therapeutics Inc. ( RNAZ ) announced on Wednesday that it has entered a definitive agreement to acquire Polynoma LLC, a privately held biotechnology firm focused on immuno-oncology. The acquisition adds Polynoma's lead candidate, seviprotimut-L, a novel polyvalent shed antigen vaccine being developed for the adjuvant treatment of stage IIB and IIC melanoma, to TransCode's development pipeline. Under the terms...
Market Chatter: Apollo Mulls Energy, Data Center Investment Opportunities in Spain
Market Chatter: Apollo Mulls Energy, Data Center Investment Opportunities in Spain
Oct 8, 2025
10:54 AM EDT, 10/08/2025 (MT Newswires) -- Apollo Global Management ( APO ) is eyeing potential investment opportunities in Spain related to energy transition, data centers and infrastructure, Bloomberg said Wednesday, citing the company's senior advisor for Iberia, Konstantin Sajonia-Coburgo. Speaking at Bloomberg's Future of Finance conference in Madrid, Sajonia-Coburgo said that with Spain's stock market representing 10% of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved